Government ❯International Relations

Global Supply Chain

Telehealth Weight Loss Drugs Restructuring Tariffs Economic Policy Semiconductors AI Industry Pharmaceuticals Competition Mergers and Acquisitions

Novo Nordisk Ends Deal With Hims & Hers Over Compounded Wegovy Copycats

Novo Nordisk cited findings that Hims & Hers continued to sell unapproved Wegovy knock-offs after FDA-declared shortages lifted.

HP to Shift 90% of North American Production Out of China, Lay Off Up to 2,000 Workers

Intel's Stock Surges on Speculation of TSMC Partnership and AI Chip Push